Concern regarding classification of germline TP53 variants as likely pathogenic

被引：5
|
作者：
Evans, D. Gareth [1 ,2 ,3 ]
Turnbull, Clare [4 ,5 ]
Woodward, Emma R. [1 ,2 ,3 ]
机构：
[1] Manchester Univ Hosp NHS Fdn Trust, Manchester Ctr Genom Med, Manchester, Lancs, England
[2] Manchester Univ Hosp NHS Fdn Trust, NW Lab Genet Hub, Manchester, Lancs, England
[3] Univ Manchester, Hlth Innovat Manchester, Fac Biol Med & Hlth, Div Evolut & Genom Sci,Sch Biol Sci, Manchester, Lancs, England
[4] Inst Canc Res, Div Genet & Epidemiol, London, England
[5] Queen Mary Univ London, William Harvey Res Inst, Dept Canc Genet, London, England
来源：
HUMAN MUTATION | 2019年 / 40卷 / 06期
关键词：
CANCER;
D O I：
10.1002/humu.23750
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
引用
收藏
页码：828 / 831
页数：4
相关论文
共 50 条
  • [21] Phenotype and prognosis of patients with breast cancer and pathogenic TP53 variants
    Petry, Vanessa
    CANCER RESEARCH, 2021, 81 (04)
  • [22] Sarcomas in TP53 Germline Mutation Carriers A Review of the IARC TP53 Database
    Ognjanovic, Simona
    Olivier, Magali
    Bergemann, Tracy L.
    Hainaut, Pierre
    CANCER, 2012, 118 (05) : 1387 - 1396
  • [23] Radiotherapy-induced malignancies in breast cancer patients with TP53 pathogenic germline variants (Li–Fraumeni syndrome)
    Vanessa Petry
    Renata Colombo Bonadio
    Allyne Queiroz Carneiro Cagnacci
    Luiz Antonio Leite Senna
    Roberta do Nascimento Galvão Campos
    Guilherme Cutait Cotti
    Paulo M. Hoff
    Maria Candida Barisson Villares Fragoso
    Maria del Pilar Estevez-Diz
    Familial Cancer, 2020, 19 : 47 - 53
  • [24] Combined germline pathogenic variants in FLCN and TP53 are associated with early onset renal cell carcinoma and brain tumors
    van de Beek, Irma
    Glykofridis, Iris E.
    Wagner, Anja
    den Toom, Dorine T.
    Bongers, Ernie M. H. F.
    van Leenders, Geert J. L. H.
    Johannesma, Paul C.
    Meijers-Heijboer, Hanne E. J.
    Wolthuis, Rob M. F.
    van Steensel, Maurice A. M.
    Dubbink, Hendrikus J.
    Houweling, Arjan C.
    MOLECULAR GENETICS & GENOMIC MEDICINE, 2023, 11 (02):
  • [25] Clinical management of TP53 mosaic variants found on germline genetic testing
    Ward, Abigail
    Farengo-Clark, Dana
    Mckenna, Danielle B.
    Safonov, Anton
    Good, Madeline
    Le, Anh
    Kessler, Lisa
    Shah, Payal D.
    Bradbury, Angela R.
    Domchek, Susan M.
    Nathanson, Katherine L.
    Powers, Jacquelyn
    Maxwell, Kara N.
    CANCER GENETICS, 2024, 284 : 43 - 47
  • [26] Blood functional assay for rapid clinical interpretation of germline TP53 variants
    Raad, Sabine
    Rolain, Marion
    Coutant, Sophie
    Derambure, Celine
    Lanos, Raphael
    Charbonnier, Francoise
    Bou, Jacqueline
    Bouvignies, Emilie
    Lienard, Gwendoline
    Vasseur, Stephanie
    Farrell, Michael
    Ingster, Olivier
    Desurmont, Stephanie Baert
    Kasper, Edwige
    Bougeard, Gaelle
    Frebourg, Thierry
    Tournier, Isabelle
    JOURNAL OF MEDICAL GENETICS, 2021, 58 (12) : 796 - 805
  • [27] Current review of TP53 pathogenic germline variants in breast cancer patients outside Li-Fraumeni syndrome
    Fortuno, Cristina
    James, Paul A.
    Spurdle, Amanda B.
    HUMAN MUTATION, 2018, 39 (12) : 1764 - 1773
  • [28] Specifications of the ACMG/AMP variant interpretation guidelines for germline TP53 variants
    Fortuno, Cristina
    Lee, Kristy
    Olivier, Magali
    Pesaran, Tina
    Mai, Phuong L.
    de Andrade, Kelvin C.
    Attardi, Laura D.
    Crowley, Stephanie
    Evans, D. Gareth
    Feng, Bing-Jian
    Foreman, Ann K. M.
    Frone, Megan N.
    Huether, Robert
    James, Paul A.
    McGoldrick, Kelly
    Mester, Jessica
    Seifert, Bryce A.
    Slavin, Thomas P.
    Witkowski, Leora
    Zhang, Liying
    Plon, Sharon E.
    Spurdle, Amanda B.
    Savage, Sharon A.
    HUMAN MUTATION, 2021, 42 (03) : 223 - 236
  • [29] Breast cancer in patients with germline TP53 pathogenic variants have typical tumour characteristics: the Cohort study of TP53 carrier early onset breast cancer (COPE study)
    Packwood, Kate
    Martland, Guy
    Sommerlad, Matthew
    Shaw, Emily
    Moutasim, Karwan
    Thomas, Gareth
    Bateman, Adrian C.
    Jones, Louise
    Haywood, Linda
    Evans, D. Gareth
    Birch, Jillian M.
    Alsalmi, Ohud A.
    Henderson, Alex
    Poplawski, Nicola
    Eccles, Diana M.
    JOURNAL OF PATHOLOGY CLINICAL RESEARCH, 2019, 5 (03): : 189 - 198
  • [30] A NOVEL FUNCTIONAL CLASSIFICATION OF TP53 GERMLINE VARIANTS: CAN THIS INFORM CANCER SCREENING PRACTICES IN YOUNG CHILDREN?
    Freycon, Claire
    Montellier, Emilie
    Budd, Crystal
    Blanchet, Sandrine
    Tachdjian, Melissa
    Hainaut, Pierre
    Goudie, Catherine
    PEDIATRIC BLOOD & CANCER, 2023, 70 : S111 - S111
12345